The 13 references in paper I. Ivanova P., V. Seledzov I., N. Banul V., D. Samarin M., G. Seledzova V., I. Savkin V., V. Shyrinsky S., N. Pronkina V., V. Kozlov A., И. Иванова П., В. Селедцов И., Н. Банул В., Д. Самарин М., Г. Селедцова В., И. Савкин В., В. Ширинский С., Н. Пронкина В., В. Козлов А. (2014) “ПОЛУЧЕНИЕ Т–КЛЕТОЧНОЙ ВАКЦИНЫ И ЕЕ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССЕЯННОГО СКЛЕРОЗА // T–CELL VACCINE PREPARATION FOR MULTIPLE SCLEROSIS TREATMENT” / spz:neicon:mimmun:y:2005:i:1:p:27-32

1
Chou Y.K, Boudete D.N., Offner H. Frequency of T cells specific for myelin basic protein and myelin pro teolipid protein in blood and cerebrospinal fluid in mul tiple sclerosis // J.Neuroimmunol. 1992. Vol.38, No 1
(check this in PDF content)
2
P.105 113. 2. Correale J., Lund B., McMillan M. T cell vaccina tion in secondary progressive multiple sclerosis.// J.Neuroimmunol. 2000. V.107, No2. P. 130 139.
(check this in PDF content)
3
Deibler G.E., Martenson R.E. and Kies M.W. Large scale preparation of myelin basic protein of sev eral mammalian species // Prep. Biochem. 1972. No2. P.139 165.
(check this in PDF content)
4
Hohlfeld R. Biotechnological agents for the im munotherapy of multiple sclerosis // Brain. 1997 V.120. P. 865 916.
(check this in PDF content)
5
Hermans G., Medaer R., Raus J., Stinissen P. My elin reactive T cells after T cell vaccination in multiple sclerosis: cytokine profile and depletion by additional immunizations // J.Neuroimmunol. 2000. V.102, No1. P.79 84.
(check this in PDF content)
6
Мor F., Cohen I.R. Experimental aspects of T cell vaccination // Clin. Exp. Rheumatol. 1993. Suppl.8. P.55 57.
(check this in PDF content)
7
Pender M.P., Csurhes P.A., Greer J.M. Surges of increased T cell reactivity to an encephalitogenic re gion of myelin proteolipid protein occur more often in patients with multiple sclerosis than in healthy subjects // The Journal of Immunology. 2000. V.165. No 9. Р. 5322 5331.
(check this in PDF content)
8
Pette M., Fujita K., Kitze B. Myelin basic protein specific T lymphocyte lines from MS patients and healthy individuals // Neurology. 1990. V. 40, No11. P. 1770 1776.
(check this in PDF content)
9
Stinissen P., Zhang J., Medaer R. Vaccination with autoreactive T cell clones in multiple sclerosis: overeiew of immunological and clinical data // J. of Neuroscience Research. 1996. V.45. P.500 511.
(check this in PDF content)
10
Stinissen P. and Raus J. Autoreactive T lympho cytes in multiple sclerosis: pathogenic role and therapeu tic targeting // Acta neurol. Belg. 1999. V.99. P.65 69.
(check this in PDF content)
11
Sun J B. Autoreactive T and B cells in nervous system diseases // Acta neurol. Scandinavica. 1993. V. 87, No142. Suppl. P.5 56.
(check this in PDF content)
12
Zang Y.C.Q., Hong J., Tejada Simon M.V. Th 2 immune regulation induced by T cell vaccination in pa tients with multiple sclerosis // Eur. J.Immunol. 2000. V.30. P. 908 913.
(check this in PDF content)
13
Zhang J., Stinissen P., Medaer R. Т cell vaccina tion: clinical application in autoimmune diseases // J.Mol.Med. 1996. V. 74. P. 653 662. поступила в редакцию 20.06.2004 отправлена на доработку 07.12.2004
(check this in PDF content)